This review will present the current studies that are helping to increase our understanding of the biological factors (clinical and non-clinical, cellular, and molecular) that may determine TKI discontinuation success
https://link.springer.com/article/10.1007/s11912-022-01228-w
Article type:
Original publication date:
Tuesday, March 1, 2022